KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Amortization - Intangibles (2019 - 2026)

Bristol Myers Squibb has reported Amortization - Intangibles over the past 8 years, most recently at $437.0 million for Q1 2026.

  • Quarterly Amortization - Intangibles fell 47.35% to $437.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.9 billion through Mar 2026, down 60.19% year-over-year, with the annual reading at $3.3 billion for FY2025, 62.61% down from the prior year.
  • Amortization - Intangibles was $437.0 million for Q1 2026 at Bristol Myers Squibb, down from $826.0 million in the prior quarter.
  • Over five years, Amortization - Intangibles peaked at $2.4 billion in Q3 2022 and troughed at $437.0 million in Q1 2026.
  • The 5-year median for Amortization - Intangibles is $2.3 billion (2023), against an average of $1.8 billion.
  • Year-over-year, Amortization - Intangibles rose 7.04% in 2024 and then plummeted 65.65% in 2025.
  • A 5-year view of Amortization - Intangibles shows it stood at $2.3 billion in 2022, then dropped by 2.77% to $2.3 billion in 2023, then fell by 25.68% to $1.7 billion in 2024, then plummeted by 51.21% to $826.0 million in 2025, then tumbled by 47.09% to $437.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Amortization - Intangibles are $437.0 million (Q1 2026), $826.0 million (Q4 2025), and $831.0 million (Q3 2025).